Table 2 Relationships between GalNAc-T3 expression and clinicopathologic features of the EBDCs
Luminal surface | Invasive front | |||||
|---|---|---|---|---|---|---|
Granular (n=41) | Diffuse (n=20) | Granular (n=26) | Diffuse (n=32) | |||
Tumor differentiation | ||||||
Papillary | 3 | 1 | NS | 0 | 0 | NS |
Tubular, well differentiated | 28 | 10 | 9 | 7 | ||
Tubular, moderately differentiated | 9 | 8 | 15 | 18 | ||
Tubular, poorly differentiated and undifferentiated | 1 | 1 | 2 | 7 | ||
Depth of invasion (T number) | ||||||
Tis | 3 | 0 | NS | 0 | 0 | NS |
T1b | 1 | 0 | 1 | 0 | ||
T2 | 14 | 8 | 10 | 12 | ||
T3 | 23 | 12 | 15 | 20 | ||
Lymphatic permeation | ||||||
Negative | 12 | 2 | NS | 6 | 5 | NS |
Positive | 29 | 18 | 20 | 27 | ||
Venous invasion | ||||||
Negative | 18 | 5 | NS | 9 | 11 | NS |
Positive | 23 | 15 | 17 | 21 | ||
Perineural invasion | ||||||
Negative | 9 | 3 | NS | 4 | 5 | NS |
Positive | 32 | 17 | 22 | 27 | ||
Lymph node metastasis | ||||||
Negative | 26 | 7 | P=0.055 | 18 | 12 | P=0.02* |
Positive | 15 | 13 | 8 | 20 | ||
TNM stage | ||||||
0 | 3 | 0 | ||||
I | 1 | 0 | 1 | 0 | ||
II | 10 | 3 | NS | 8 | 5 | NS |
III | 4 | 5 | 2 | 7 | ||
IVA | 23 | 12 | 15 | 20 | ||
